Guilin Layn Natural Ingredients Corp. (SHE:002166)
China · Delayed Price · Currency is CNY 8.83
-0.10 (-1.12%)
At close: Feb 13, 2026
SHE:002166 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,827 | 1,725 | 1,484 | 1,322 | 1,006 | 733.57 |
Other Revenue | 46.5 | 46.5 | 9.83 | 78.78 | 46.89 | 50.1 |
| 1,874 | 1,772 | 1,494 | 1,401 | 1,053 | 783.67 | |
Revenue Growth (YoY) | 5.58% | 18.60% | 6.65% | 32.99% | 34.40% | 5.70% |
Cost of Revenue | 1,386 | 1,272 | 1,166 | 992.68 | 748.76 | 574.05 |
Gross Profit | 488.37 | 499.77 | 327.72 | 408.05 | 304.47 | 209.62 |
Selling, General & Admin | 208.11 | 202.63 | 192.78 | 148.63 | 121.66 | 104.63 |
Research & Development | 60.55 | 57.5 | 48.39 | 44.26 | 38.98 | 24.04 |
Other Operating Expenses | 17.87 | 6.68 | 8.38 | 5.82 | 5.36 | 3.76 |
Operating Expenses | 306.03 | 285.3 | 252.75 | 199.01 | 166.96 | 132.09 |
Operating Income | 182.34 | 214.47 | 74.97 | 209.04 | 137.52 | 77.53 |
Interest Expense | -40.96 | -42.24 | -32.9 | -27.72 | -24.65 | -18.15 |
Interest & Investment Income | 8.26 | 11.41 | 12.72 | 12.79 | 6.73 | 9.36 |
Currency Exchange Gain (Loss) | 8.76 | 8.76 | 1.56 | 10.47 | -3 | -5.64 |
Other Non Operating Income (Expenses) | 0.42 | -2.79 | 5.41 | -1.21 | -0.64 | 1.52 |
EBT Excluding Unusual Items | 158.82 | 189.61 | 61.77 | 203.37 | 115.96 | 64.62 |
Gain (Loss) on Sale of Investments | 13.01 | 2.03 | 45.35 | 35.63 | 12.54 | 16.08 |
Gain (Loss) on Sale of Assets | -2.2 | -0.52 | -0.71 | -0.08 | -0.81 | - |
Asset Writedown | -2.36 | -1.12 | -8.05 | -0.02 | - | -1.58 |
Other Unusual Items | 17.76 | 17.85 | 18.01 | -0.56 | 24.24 | 19.85 |
Pretax Income | 185.02 | 207.84 | 116.36 | 238.34 | 151.94 | 98.97 |
Income Tax Expense | 44.67 | 40.66 | 18.02 | 50.04 | 20.75 | 12.79 |
Earnings From Continuing Operations | 140.35 | 167.17 | 98.35 | 188.29 | 131.19 | 86.18 |
Minority Interest in Earnings | -8.57 | -4.17 | -15.84 | -9.55 | -12.75 | -0.19 |
Net Income | 131.78 | 163.01 | 82.51 | 178.74 | 118.44 | 85.99 |
Net Income to Common | 131.78 | 163.01 | 82.51 | 178.74 | 118.44 | 85.99 |
Net Income Growth | -7.99% | 97.56% | -53.84% | 50.91% | 37.74% | -18.61% |
Shares Outstanding (Basic) | 725 | 741 | 750 | 616 | 564 | 573 |
Shares Outstanding (Diluted) | 725 | 741 | 750 | 616 | 564 | 573 |
Shares Change (YoY) | -7.50% | -1.22% | 21.70% | 9.28% | -1.62% | 8.52% |
EPS (Basic) | 0.18 | 0.22 | 0.11 | 0.29 | 0.21 | 0.15 |
EPS (Diluted) | 0.18 | 0.22 | 0.11 | 0.29 | 0.21 | 0.15 |
EPS Growth | -0.53% | 100.00% | -62.07% | 38.09% | 40.00% | -25.00% |
Free Cash Flow | 193.76 | -47.37 | -313.37 | -377.38 | -152.58 | -103.68 |
Free Cash Flow Per Share | 0.27 | -0.06 | -0.42 | -0.61 | -0.27 | -0.18 |
Dividend Per Share | 0.100 | 0.100 | 0.200 | 0.100 | - | 0.050 |
Dividend Growth | -50.00% | -50.00% | 100.00% | - | - | - |
Gross Margin | 26.06% | 28.21% | 21.94% | 29.13% | 28.91% | 26.75% |
Operating Margin | 9.73% | 12.11% | 5.02% | 14.92% | 13.06% | 9.89% |
Profit Margin | 7.03% | 9.20% | 5.52% | 12.76% | 11.24% | 10.97% |
Free Cash Flow Margin | 10.34% | -2.67% | -20.98% | -26.94% | -14.49% | -13.23% |
EBITDA | 290.35 | 312.61 | 159.95 | 280.52 | 192.93 | 117.11 |
EBITDA Margin | 15.49% | 17.64% | 10.71% | 20.03% | 18.32% | 14.94% |
D&A For EBITDA | 108.01 | 98.14 | 84.98 | 71.47 | 55.41 | 39.58 |
EBIT | 182.34 | 214.47 | 74.97 | 209.04 | 137.52 | 77.53 |
EBIT Margin | 9.73% | 12.11% | 5.02% | 14.92% | 13.06% | 9.89% |
Effective Tax Rate | 24.14% | 19.56% | 15.48% | 21.00% | 13.66% | 12.92% |
Revenue as Reported | 1,874 | 1,772 | 1,494 | 1,401 | 1,053 | 783.67 |
Advertising Expenses | - | 8.77 | 6.53 | 6.09 | 4.08 | 2.63 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.